ISPOR OUTLINES NEW STRATEGIC VISION AT 18th ANNUAL EUROPEAN CONGRESS

Published Nov 10, 2015

ISPOR UPDATES STRATEGY IN ITS 20th ANNIVERSARY YEAR 

Milan, Italy—November 10, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) outlined the organization’s updated strategic vision this morning during its member meeting at the 18th Annual European Congress in Milan, Italy. ISPOR President Daniel C. Malone, RPh, PhD and CEO Nancy Berg presented ISPOR’s new organizational strategy, an update of ISPOR’s Vision 2020, the current strategic plan. ISPOR’s new Mission Statement to promote health economics and outcomes research excellence to improve decision making for health globally is supported by five strategic pillars:
  1. Scientific and Research Excellence
  2. Member Engagement
  3. Education and Training
  4. Communication and Collaboration
  5. Organizational Values
“We are very excited to introduce ISPOR’s new strategic vision to our members,” noted Berg. “Our updated strategy was developed by ISPOR’s Strategic Planning Working Group and approved by the ISPOR Board with input from many members.” In his comments, Malone emphasized the Society’s commitment to strengthen the integrity, advancement, and understanding of health economics and outcomes research globally. Additional information on ISPOR’s updated strategic vision may be found at http://www.ispor.org/mission.asp. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.

###

Related Stories

Advancing the Economics of Mental Health: A Global Perspective

Mar 12, 2025

Value in Health, the official journal of ISPOR announced the publication of a special themed section of research papers exploring mental health economics, highlighting impacts on caregivers, productivity, and interventions’ cost-effectiveness.

ISPOR Introduces Corporate Partner Program

Feb 25, 2025

ISPOR announced its new Corporate Partnership Program that is designed to provide organizations with comprehensive, year-round engagement with the global health economics and outcomes research (HEOR) audience.

Generative AI Set to Reshape Health Technology Assessment, ISPOR Report Finds

Feb 11, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of an ISPOR Working Group Report that provides an introduction to the uses of generative artificial intelligence (AI) in health technology assessment (HTA).
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×